354 related articles for article (PubMed ID: 33487427)
21. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
22. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
[TBL] [Abstract][Full Text] [Related]
23. Outcome of thoracoscopic anatomical sublobar resection under 3-dimensional computed tomography simulation.
Hamada A; Oizumi H; Kato H; Suzuki J; Nakahashi K; Takamori S; Sho R; Sadahiro M
Surg Endosc; 2022 Apr; 36(4):2312-2320. PubMed ID: 33881626
[TBL] [Abstract][Full Text] [Related]
24. Non-small cell lung cancer: when to offer sublobar resection.
Sihoe AD; Van Schil P
Lung Cancer; 2014 Nov; 86(2):115-20. PubMed ID: 25249427
[TBL] [Abstract][Full Text] [Related]
25. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J
Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420
[TBL] [Abstract][Full Text] [Related]
26. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
[TBL] [Abstract][Full Text] [Related]
27. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
28. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
Shimada Y; Saji H; Otani K; Maehara S; Maeda J; Yoshida K; Kato Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Akata S; Ikeda N
Lung Cancer; 2015 May; 88(2):174-80. PubMed ID: 25758554
[TBL] [Abstract][Full Text] [Related]
29. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y
Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995
[TBL] [Abstract][Full Text] [Related]
30. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
Trials; 2016 Apr; 17():191. PubMed ID: 27053091
[TBL] [Abstract][Full Text] [Related]
31. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.
Yoshida J; Ishii G; Hishida T; Aokage K; Tsuboi M; Ito H; Yokose T; Nakayama H; Yamada K; Nagai K
Jpn J Clin Oncol; 2015 Jul; 45(7):677-81. PubMed ID: 25900903
[TBL] [Abstract][Full Text] [Related]
32. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
33. [JCOG lung cancer surgery trial series: review and interpretation].
Li RZ; Qiu B
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):703-711. PubMed ID: 35880335
[TBL] [Abstract][Full Text] [Related]
34. Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer
Suh JW; Jeong YH; Cho A; Kim DJ; Chung KY; Shim HS; Lee CY
Lung Cancer; 2020 Apr; 142():28-33. PubMed ID: 32065918
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Resection Margin Distance and Invasive Component Size on Recurrence After Sublobar Resection in Patients With Small (≤2 Cm) Lung Adenocarcinoma.
Moon Y; Park JK; Lee KY
World J Surg; 2020 Mar; 44(3):990-997. PubMed ID: 31712844
[TBL] [Abstract][Full Text] [Related]
36. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
37. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
Yoshioka M; Ichiguchi O
Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
[TBL] [Abstract][Full Text] [Related]
38. Sublobar resection in non-small cell lung cancer: patient selection criteria and risk factors for recurrence.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Br J Radiol; 2023 Oct; 96(1150):20230143. PubMed ID: 37561432
[TBL] [Abstract][Full Text] [Related]
39. Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.
Hattori A; Takamochi K; Matsunaga T; Oh S; Suzuki K
Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):18-24. PubMed ID: 26486132
[TBL] [Abstract][Full Text] [Related]
40. Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer?
Zuin A; Andriolo LG; Marulli G; Schiavon M; Nicotra S; Calabrese F; Romanello P; Rea F
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e120-5; discussion e125. PubMed ID: 23657547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
